Medrx Co (TSE:4586) Cash Payments

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4586 Medrx Co Ltd TSE:4586
61 GF Score
Price 円61.00
GF Value 円70.61
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Medrx Co Cash Payments?

Cash Payments only applicable to companies reporting Cash Flow from Operations in direct method.

TSE:4586
61GF Score
Medrx Co Ltd TSE:4586
Cash Payments is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Medrx Co (TSE:4586) Overvalued in 2026?

Based on GuruFocus' analysis, Medrx Co stock appears to be undervalued. The current stock price of 円61.00 is trading 13.6% below its estimated GF Value™ of 円70.61. GuruFocus considers Medrx Co to be Modestly Undervalued.

Key valuation signals for TSE:4586:

  • Cash Payments:
  • GF Value™: 円70.61 vs. price of 円61.00 (13.6% below fair value)
  • GF Score™: 61/100 with 3 warning signs

No single metric tells the full story. See the TSE:4586 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Medrx Co Business Description

Address 431-7 Nishiyama, Higashikagawa, Kagawa, JPN, 769-2712
Medrx Co Ltd is a pharmaceutical drug development company founded in January, 2002. The Company engaged in the research and development of pharmaceutical products utilizing the pharmaceutical formulation technology based on ionic liquid transdermal system. The Company develops new pharmaceutical candidates and licenses other companies to produce the pharmaceuticals after clinical trials. Its main products include analgesic patches for anti-inflammatory and pain relief.
61GF Score

Get the complete analysis for TSE:4586

Cash Payments is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円61.00
Price
円70.61
GF Value